Drug Trial Radar · NCT05889156
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
Last checked: Nov 19, 2026Latest source record: Apr 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Jun 30, 2023
Primary completion
Mar 18, 2025
Study completion Apr 11, 2025
Sponsor
- Lead sponsor
- NorthSea Therapeutics B.V.Industry
- Sponsor type
- Industry
- First posted
- Jun 5, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase IIa,multicentre proof of concept study consisting of 2 study periods to study Treatment with NST-1024 as an adjunct to diet to reduce triglyceride (TG) levels in subjects with TG levels of ≥500 mg/dL and ≤2000 mg/dL; determined by percentage change in TG from baseline after 28 days of treatment. The two periods consist of: 1. A 3-week screening period that includes a TG qualifying period, and 2. A 28-days, double-blind, randomized, parallel group, placebo-controlled treatment period. Subjects will return to the study site for a follow-up visit 2 weeks after the last dose. Approximately 50 subjects will be randomized at approximately 15-35 centers in USA.
Conditions
- High Triglycerides
Interventions
NST-1024Drug
400 mg BID
PlaceboOther
matched placebo to active arm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the efficacy of NST-1024 by percentage change in TGTime frame: 4 weeks
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama - Heersink School of Medicine
Birmingham, Alabama
Alliance for Multispecialty Research, LLC (AMR) - Daphne
Daphne, Alabama
Alliance for Multispecialty Research, LLC (AMR) - Phoenix
Tempe, Arizona
Velocity Clinical Research, San Diego
La Mesa, California
Velocity Clinical Research, North Hollywood
North Hollywood, California
Velocity Clinical Research - Costal Heart
Santa Ana, California
Lynn Institute of Denver
Aurora, Colorado
Velocity Clinical Research, New Smyrna Beach
Edgewater, Florida
Clearwater Cardiovascular Consultants
Largo, Florida
Floridian Clinical Research
Miami Lakes, Florida
Metabolic Research Institute, Inc.
West Palm Beach, Florida
Lifeline Primary Care/ CCT Research
Lilburn, Georgia
Velocity Clinical Research - Boise
Meridian, Idaho
Deaconess Clinic - Indiana
Evansville, Indiana
Velocity Clinical Research, Valparaiso
Valparaiso, Indiana
Alliance for Multispecialty Research, LLC (AMR) - Newton
Newton, Kansas
University of Louisville - UoL Physicians Outpatient Center
Louisville, Kentucky
Troy Internal Medicine
Troy, Michigan
Clay Platte Family Medicine / CCT Research
Kansas City, Missouri
Velocity Clinical Research - Kearney
Lincoln, Nebraska
Cenexel HRI
Berlin, New Jersey
Velocity Clinical Research - Cincinnati
Cincinnati, Ohio
Velocity Clinical Research - Cleveland
Cleveland, Ohio
Hatboro Medical Associates/ CCT Research
Hatboro, Pennsylvania
Mercado Medical Practice / CCT Research
Philadelphia, Pennsylvania
Palmetto Clinical Reserach
Summerville, South Carolina
Velocity Clinical Research - Union
Union, South Carolina
Apex Mobile Clinical Research
Bellaire, Texas
Pinnacle Clinical Research - San Antonio
San Antonio, Texas
Ogden Clinic, Mount View/CCT Research
Pleasant View, Utah
Velocity Clinical Research - Salt Lake City
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.